Genmab A/S (CPH:GMAB)
1,953.50
-11.00 (-0.56%)
Nov 14, 2025, 4:59 PM CET
Genmab Revenue
Genmab had revenue of $1.02B USD in the quarter ending September 30, 2025, with 23.34% growth. This brings the company's revenue in the last twelve months to $3.85B, up 29.57% year-over-year. In the year 2024, Genmab had annual revenue of $2.99B with 22.32% growth.
Revenue (ttm)
$3.85B
Revenue Growth
+29.57%
P/S Ratio
4.91
Revenue / Employee
$1.43M
Employees
2,682
Market Cap
120.27B DKK
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.99B | 545.24M | 22.32% |
| Dec 31, 2023 | 2.44B | 358.99M | 17.23% |
| Dec 31, 2022 | 2.08B | 796.62M | 61.88% |
| Dec 31, 2021 | 1.29B | -374.23M | -22.52% |
| Dec 31, 2020 | 1.66B | 855.79M | 106.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 315.60B |
| Coloplast | 27.87B |
| H. Lundbeck | 24.08B |
| Demant | 22.59B |
| GN Store Nord | 17.12B |
| Zealand Pharma | 9.16B |
| Bavarian Nordic | 6.89B |
| ALK-Abelló | 6.08B |
Genmab News
- 5 days ago - Genmab Provides Certain Information Disclosed in Connection with Proposed Private Offering of Senior Secured Notes and Senior Unsecured Notes - GlobeNewsWire
- 5 days ago - Zscaler To Rally More Than 9%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
- 5 days ago - Genmab Announces Proposed Private Offering of Senior Secured Notes and Senior Unsecured Notes and Syndication of New Senior Secured Term Loan Facility - GlobeNewsWire
- 7 days ago - Genmab A/S (GMAB) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Genmab AS (GMAB) Q3 2025 Earnings Call Highlights: Robust Revenue Growth and Strategic ... - GuruFocus
- 9 days ago - Q3 2025 Genmab A/S Earnings Call Transcript - GuruFocus
- 9 days ago - Genmab Nine-Mont Profit Rises - Nasdaq
- 9 days ago - Genmab (GMAB) Expects Revenue Boost by 2025 Due to Increased Sales and Collaborations - GuruFocus